Becton Dickinson & Co. Stock Underperforms Friday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Becton Dickinson & Co. (BDX) shares fell 1.10% to $158.17 on Friday, underperforming the broader market and snapping a two-day winning streak. The decline occurred during a dismal trading session where the S&P 500 dropped 1.01% and the Dow Jones Industrial Average fell 0.77%. BDX closed 15.58% below its 52-week high of $187.35. Compared to competitors like Danaher, Medtronic, and DexCom, BDX's performance was mixed as all major peers also experienced declines.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Becton Dickinson & Co. (BDX) shed 1.10% to $158.17 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 1.01% to 7,457.69 and Dow Jones Industrial Average falling 0.77% to 52,146.42.
The stock's fall snapped a two-day winning streak.
Becton Dickinson & Co. closed 15.58% short of its 52-week high of $187.35, which the company achieved on February 24th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Danaher Corp. (DHR) fell 0.58% to $203.83, Medtronic PLC (MDT) fell 0.43% to $83.20, and DexCom Inc. (DXCM) fell 1.71% to $76.65.
Data source: Dow Jones Market Data, FactSet. Data compiled July 17, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-17-26 1652ET